Epidermal growth factor receptor inhibitors (EGFR inhibitors) are used extensively to treat various cancers, such as non-small-cell lung cancer, breast, head and neck, and pancreatic cancer [112]. This evidence concerns the gene EGFR and familial pancreatic carcinoma.